Active-ingredient Dossier

Filgrastim

Active-ingredient Dossier for Filgrastim (granulocyte colony stimulating factor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…

Brand: NIVESTIM
Brand: ZARZIO
Brand: TEVAGRASTIM
Therapeutic area: Haematology
Therapeutic area: Oncology

What is

Filgrastim Filgrastim is a granulocyte colony stimulating factor.

Australian brands containing

Filgrastim — NIVESTIM — ZARZIO — TEVAGRASTIM

Therapeutic areas

Filgrastim is registered in oncology (2 brands) and haematology (1 brand).

Sponsor landscape

Filgrastim is marketed by three sponsors: Pfizer, Teva Pharma, and Sandoz.

PBS and regulatory activity

Two brands containing filgrastim have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 April 2018, and the latest AusPAR was issued on 2 May 2013.